| Year |
Citation |
Score |
| 2022 |
Baust JM, Santucci KL, Van Buskirk RG, Raijman I, Fisher WE, Baust JG, Snyder KK. An In Vitro Investigation into Cryoablation and Adjunctive Cryoablation/Chemotherapy Combination Therapy for the Treatment of Pancreatic Cancer Using the PANC-1 Cell Line. Biomedicines. 10. PMID 35203660 DOI: 10.3390/biomedicines10020450 |
0.722 |
|
| 2022 |
Baust JM, Snyder KK, Van Buskirk RG, Baust JG. Assessment of the Impact of Post-Thaw Stress Pathway Modulation on Cell Recovery following Cryopreservation in a Hematopoietic Progenitor Cell Model. Cells. 11. PMID 35053394 DOI: 10.3390/cells11020278 |
0.745 |
|
| 2020 |
Santucci KL, Baust JM, Snyder KK, Van Buskirk RG, Katz A, Corcoran A, Baust JG. Investigation of Bladder Cancer Cell Response to Cryoablation and Adjunctive Cisplatin Based Cryo/Chemotherapy. Clinical Research (Milpitas, Calif.). 6. PMID 35128225 DOI: 10.16966/2469-6714.154 |
0.731 |
|
| 2020 |
Snyder KK, Van Buskirk RG, Baust JG, Baust JM. Breast Cancer Cryoablation: Assessment of the Impact of Fundamental Procedural Variables in an In Vitro Human Breast Cancer Model. Breast Cancer : Basic and Clinical Research. 14: 1178223420972363. PMID 33239880 DOI: 10.1177/1178223420972363 |
0.683 |
|
| 2019 |
Baust JG, Snyder KK, Santucci KL, Robilotto AT, Van Buskirk RG, Baust JM. Cryoablation: physical and molecular basis with putative immunological consequences. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 36: 10-16. PMID 31795837 DOI: 10.1080/02656736.2019.1647355 |
0.673 |
|
| 2018 |
Baust JM, Robilotto A, Guerra P, Snyder KK, Van Buskirk RG, Dubuc M, Baust JG. Assessment of a novel cryoablation device for the endovascular treatment of cardiac tachyarrhythmias. Sage Open Medicine. 6: 2050312118769797. PMID 29770216 DOI: 10.1177/2050312118769797 |
0.632 |
|
| 2018 |
Baust JM, Rabin Y, Polascik TJ, Santucci KL, Snyder KK, Van Buskirk RG, Baust JG. Defeating Cancers' Adaptive Defensive Strategies Using Thermal Therapies: Examining Cancer's Therapeutic Resistance, Ablative, and Computational Modeling Strategies as a means for Improving Therapeutic Outcome. Technology in Cancer Research & Treatment. 17: 1533033818762207. PMID 29566612 DOI: 10.1177/1533033818762207 |
0.692 |
|
| 2018 |
Santucci KL, Baust JM, Snyder KK, Van Buskirk RG, Baust JG. Dose Escalation of Vitamin DYields Similar Cryosurgical Outcome to Single Dose Exposure in a Prostate Cancer Model. Cancer Control : Journal of the Moffitt Cancer Center. 25: 1073274818757418. PMID 29480024 DOI: 10.1177/1073274818757418 |
0.701 |
|
| 2017 |
Baust JM, Robilotto A, Snyder KK, Santucci K, Stewart J, Van Buskirk R, Baust JG. Assessment of Cryosurgical Device Performance Using a 3D Tissue-Engineered Cancer Model. Technology in Cancer Research & Treatment. 1533034617708960. PMID 28514898 DOI: 10.1177/1533034617708960 |
0.671 |
|
| 2017 |
Baust JG, Snyder KK, Van Buskirk R, Baust JM. Integrating Molecular Control to Improve Cryopreservation Outcome. Biopreservation and Biobanking. PMID 28332850 DOI: 10.1089/Bio.2016.0119 |
0.738 |
|
| 2016 |
Baust JM, Corwin W, Snyder KK, Van Buskirk R, Baust JG. Cryopreservation: Evolution of Molecular Based Strategies. Advances in Experimental Medicine and Biology. 951: 13-29. PMID 27837551 DOI: 10.1007/978-3-319-45457-3_2 |
0.768 |
|
| 2016 |
Baumann KW, Baust JM, Snyder KK, Baust JG, Van Buskirk RG. Characterization of Pancreatic Cancer Cell Thermal Response to Heat Ablation or Cryoablation. Technology in Cancer Research & Treatment. PMID 27340260 DOI: 10.1177/1533034616655658 |
0.708 |
|
| 2016 |
Santucci KL, Baust JM, Snyder KK, Van Buskirk RG, Baust JG. Investigation of the Impact of Cell Cycle Stage on Freeze Response Sensitivity of Androgen-Insensitive Prostate Cancer. Technology in Cancer Research & Treatment. PMID 27161856 DOI: 10.1177/1533034616648059 |
0.724 |
|
| 2014 |
Corwin WL, Baust JM, Baust JG, Van Buskirk RG. Characterization and modulation of human mesenchymal stem cell stress pathway response following hypothermic storage. Cryobiology. 68: 215-26. PMID 24508650 DOI: 10.1016/J.Cryobiol.2014.01.014 |
0.753 |
|
| 2013 |
Corwin WL, Baust JM, Baust JG, Van Buskirk RG. Implications of differential stress response activation following non-frozen hepatocellular storage. Biopreservation and Biobanking. 11: 33-44. PMID 24845253 DOI: 10.1089/Bio.2012.0045 |
0.757 |
|
| 2011 |
Corwin WL, Baust JM, Baust JG, Van Buskirk RG. The unfolded protein response in human corneal endothelial cells following hypothermic storage: implications of a novel stress pathway. Cryobiology. 63: 46-55. PMID 21549109 DOI: 10.1016/J.Cryobiol.2011.04.008 |
0.764 |
|
| 2011 |
Santucci KL, Snyder KK, Baust JM, Van Buskirk RG, Mouraviev V, Polascik TJ, Gage AA, Baust JG. Use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model. Prostate Cancer and Prostatic Diseases. 14: 97-104. PMID 21221127 DOI: 10.1038/Pcan.2010.52 |
0.764 |
|
| 2007 |
Robilotto AT, Clarke D, Baust JM, Van Buskirk RG, Gage AA, Baust JG. Development of a tissue engineered human prostate tumor equivalent for use in the evaluation of cryoablative techniques. Technology in Cancer Research & Treatment. 6: 81-9. PMID 17375970 DOI: 10.1177/153303460700600204 |
0.727 |
|
| 2004 |
Mathew AJ, Baust JM, Van Buskirk RG, Baust JG. Cell preservation in reparative and regenerative medicine: evolution of individualized solution composition. Tissue Engineering. 10: 1662-71. PMID 15684675 DOI: 10.1089/Ten.2004.10.1662 |
0.726 |
|
| 2004 |
Clarke DM, Baust JM, Van Buskirk RG, Baust JG. Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement. Cryobiology. 49: 45-61. PMID 15265716 DOI: 10.1016/J.Cryobiol.2004.05.003 |
0.727 |
|
| 2004 |
Baust JG, Gage AA, Clarke D, Baust JM, Van Buskirk R. Cryosurgery--a putative approach to molecular-based optimization. Cryobiology. 48: 190-204. PMID 15094094 DOI: 10.1016/J.Cryobiol.2004.01.005 |
0.753 |
|
| 2002 |
Baust JM, Van Buskirk R, Baust JG. Modulation of the cryopreservation cap: elevated survival with reduced dimethyl sulfoxide concentration. Cryobiology. 45: 97-108. PMID 12482375 DOI: 10.1016/S0011-2240(02)00100-1 |
0.313 |
|
| 2001 |
Clarke DM, Baust JM, Van Buskirk RG, Baust JG. Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer. Cryobiology. 42: 274-85. PMID 11748936 DOI: 10.1006/Cryo.2001.2333 |
0.749 |
|
| Show low-probability matches. |